Delhi's Connaught Place world's 9th most expensive office area: Report
New Delhi, July 11: Connaught Place in Delhi is the ninth most expensive office location in the world, a CBRE report said here on Wednesday.
"Delhi's Connaught Place moved one notch up to be the ninth most expensive office location with an annual prime rent of $153.26 per square feet from last year's tenth most expensive office location," said the report titled "Global Prime Office Occupancy Costs 2018".
Meanwhile, Mumbai's Bandra Kurla Complex moved down to the 26th position with an annual prime rent of $96.51 per square feet and the central business district in Nariman Point, Mumbai fell from 30th to 37th position with an annual prime rent of $72.80 per square feet, it said.
The most expensive office location in the world is Hong Kong (Central) with annual prime rent of $306.57 per square feet, according to the report. The city held on to the top position for the second consecutive year, it said.
London (West End) and Finance Street in Beijing were second and third in the list.
CBRE's Chairman, India and South-East Asia Anshuman Magazine said: "Strong demand from finance, technology and the e-commerce sectors has fuelled the growth momentum in prime occupancy costs from last year and commercial office market remains a strong growth propeller for the real estate sector."
Let the Truth be known. If you read VB and like VB, please be a VB Supporter and Help us deliver the Truth to one and all.
Statewide ban on IV Ringer Lactate usage: Dinesh Gundu Rao
Bengaluru: In response to the deaths of postnatal women at Ballari District Hospital, the Karnataka government has temporarily suspended the use of IV Ringer Lactate solution across the state as a precautionary measure, Health Minister Dinesh Gundu Rao announced on Saturday.
Speaking to the media in Bengaluru, the minister explained that doubts about the quality of the IV solution had arisen, prompting the decision. He clarified that Ringer Lactate, along with glucose solutions, has been routinely used in hospitals for years. However, out of the 192 batches supplied by the Karnataka State Drugs Logistics and Warehousing Society, concerns were raised regarding two specific batches.
"In light of these concerns, we stopped the use of all 192 batches as a precaution. Following this, the supplying company obtained a High Court order for testing, and the Central Drugs Laboratory (CDL) conducted an analysis. The CDL report confirmed the usability of the solution, allowing the state to form a technical committee to review and permit the use of certain batches that met quality standards. Despite this, doubts have surfaced specifically at Ballari District Hospital," the minister stated.
To address these concerns, the batches supplied to Ballari Hospital have been sent for anaerobic testing to determine whether the IV solution contributed to the deaths. The test results are expected within a week, after which a final decision on the use of IV Ringer Lactate will be made.
"Until then, we have issued directives to hospitals statewide to suspend the use of IV Ringer Lactate. Every life is important to us, and precautionary measures are essential when suspicions arise," Gundu Rao emphasised.
